Stock SCNI SCINAI IMMUNOTHERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Scinai Immunotherapeutics Ltd.

Equities

SCNI

US09073Q2049

Biotechnology & Medical Research

Delayed Nasdaq
Other stock markets
 11:38:22 2024-04-29 am EDT 		5-day change 1st Jan Change
0.45 USD -1.71% Intraday chart for Scinai Immunotherapeutics Ltd. -1.96% -24.42%
Apr. 08 Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls MT
Apr. 08 Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 31.17 93.45 32.39 43.42 10.32 1.992
Enterprise Value (EV) 1 31.17 93.45 32.39 43.42 10.32 1.992
P/E ratio -50.6 x -98 x -23.1 x -2.71 x -0.74 x -0.26 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 654 1,006 1,153 1,848 3,486 4,352
Reference price 2 47.70 92.90 28.10 23.50 2.960 0.4578
Announcement Date 4/30/19 6/12/20 5/13/21 3/28/22 4/17/23 -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 - - - - - -
EBITDA - - - - - -
EBIT 1 -21.32 -22.68 - -10.83 -11.06 -10.38
Operating Margin - - - - - -
Earnings before Tax (EBT) -24.27 -31.61 - -12.43 -5.796 -
Net income 1 -24.27 -31.61 -1.356 -12.43 -5.796 -7.08
Net margin - - - - - -
EPS 2 -0.9436 -0.9476 -1.217 -8.681 -4.000 -1.780
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/30/19 6/12/20 5/13/21 3/28/22 4/17/23 -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT 1 - -3.402 -2.492 -3.301 1.123 -6.77 -3.186 -2.595 -2.102 -2.5
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) 1 - -3.343 -2.831 -3.935 1.089 -0.568 - -3.762 3.107 -
Net income 1 -2.86 -3.343 -2.831 -3.935 1.089 -0.568 -3.515 -3.762 3.107 -2.91
Net margin - - - - - - - - - -
EPS 2 -2.530 -2.480 -2.393 -0.0612 0.0291 - -1.200 -1.200 0.8000 -0.6200
Dividend per Share - - - - - - - - - -
Announcement Date 11/30/21 3/28/22 6/1/22 8/25/22 11/30/22 4/17/23 5/15/23 8/11/23 10/31/23 -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/30/19 6/12/20 5/13/21 3/28/22 4/17/23 -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4578 USD
Average target price
70 USD
Spread / Average Target
+15,189.45%
Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SCINAI IMMUNOTHERAPEUTICS LTD. Stock Scinai Immunotherapeutics Ltd.
-24.42% 1.99M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+2.66% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+47.70% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+12.23% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.99% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.90% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.39% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.40% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.66% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SCNI Stock
  4. Financials Scinai Immunotherapeutics Ltd.